Vasculitis

Giant Cell Arteritis Risk High in Patients Older Than 80 Years

Publish Date November 29, 2021

The investigation shows women and White patients are most likely to be affected.

Accuracy of Vascular Ultrasound Determined for the Diagnosis of Suspected Giant Cell Arteritis

Publish Date November 23, 2021

Researchers evaluated the diagnostic accuracy of ultrasound examination in patients with suspected giant cell arteritis.

Study Reveals New Insights Into Predictors of Mortality in Patients With VEXAS Syndrome

Publish Date November 11, 2021

Researchers aimed to provide deeper insight into the predictors of mortality and survival in patients with VEXAS syndrome.

Standard Rituximab Dose May Be Inadequate to Maintain B-Cell Depletion in ANCA-Associated Vasculitis

Publish Date November 4, 2021

Researchers evaluated the pharmacologic response of rituximab dosing for maintenance therapy in patients with ANCA-associated vasculitis.

Reference “Atlas” Useful in Diagnosis, Management of Hughes‑Stovin Syndrome-Related Pulmonary Vasculitis

Publish Date October 18, 2021

Members of the Hughes-Stovin syndrome (HSS) International Study Group developed a reference “atlas” of images to describe the characteristic features of HSS and inform diagnosis and management of HSS-related pulmonary vasculitis.

Avacopan Approved for ANCA-Associated Vasculitis

Publish Date October 15, 2021

The approval was based on data from the phase 3 ADVOCATE trial, which evaluated Tavneos in 330 adults with newly diagnosed or relapsed ANCA-associated vasculitis.

Case Report: Eosinophilic Granulomatosis With Polyangiitis After Prolonged Intervals of Tocilizumab in Rheumatoid Arthritis

Publish Date September 29, 2021

Authors reported the case of an 83-year-old woman with a history of asthma and rheumatoid arthritis who presented with left abdominal pain.

Adalimumab Biosimilar Reduces Uveitis Relapse, Retinal Vasculitis

Publish Date September 27, 2021

Recurrence dropped dramatically from 115 per 100 patients each year to before the start of SB5 to 3 relapses per 100 patients each year with the treatment.

Giant Cell Arteritis Linked to Higher Incidence of Hematologic and Solid Malignancies

Publish Date August 30, 2021

Using a large nationwide electronic database, researchers assessed the association between giant cell arteritis and risk for malignancies.

2021 ACR/Vasculitis Foundation Recommendations for the Management of Giant Cell Arteritis and Takayasu Arteritis

Publish Date August 13, 2021

The American College of Rheumatology and Vasculitis Foundation released evidence-based recommendations for the management of giant cell arteritis and Takayasu arteritis.